Moderna Inc. (MRNA) Balance Sheet Analysis - Assets, Liabilities & Financial Position - Stocknear
Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Start Trial

    Moderna Inc.

    NASDAQ: MRNA · Real-Time Price · USD
    24.49
    -0.12 (-0.49%)
    At close: Sep 26, 2025, 3:59 PM
    24.49
    0.00%
    After-hours: Sep 26, 2025, 07:53 PM EDT

    Moderna Balance Sheet Statement

    Financials in USD. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
    Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
    Cash & Equivalents
    		 1.93B 2.91B 3.21B 6.85B
    Short-Term Investments
    		 5.1B 5.7B 6.7B 3.88B
    Long-Term Investments
    		 2.51B 4.74B 8.36B 6.84B
    Other Long-Term Assets
    		 407M 523M 946M 46M
    Receivables
    		 592M 1.08B 1.69B 3.32B
    Inventory
    		 117M 202M 949M 1.44B
    Other Current Assets
    		 58M 88M 44M 26M
    Total Current Assets
    		 8.1B 10.32B 13.43B 16.07B
    Property-Plant & Equipment
    		 2.96B 2.66B 2.14B 1.38B
    Goodwill & Intangibles
    		 92M 96M n/a n/a
    Total Long-Term Assets
    		 6.04B 8.1B 12.43B 8.6B
    Total Assets
    		 14.14B 18.43B 25.86B 24.67B
    Account Payables
    		 405M 520M 487M 302M
    Deferred Revenue
    		 153M 568M 2.04B 6.25B
    Short-Term Debt
    		 n/a n/a n/a n/a
    Other Current Liabilities
    		 863M 842M 243M 140M
    Total Current Liabilities
    		 2.21B 3.02B 4.92B 9.13B
    Long-Term Debt
    		 n/a n/a n/a n/a
    Other Long-Term Liabilities
    		 267M 256M 135M 76M
    Total Long-Term Liabilities
    		 1.03B 1.56B 1.81B 1.4B
    Total Liabilities
    		 3.24B 4.57B 6.74B 10.52B
    Total Debt
    		 747M 1.24B 1.2B 916M
    Book Value
    		 10.9B 13.85B 19.12B 14.14B
    Book Value Per Share
    		 28.39 36.27 48.54 35.10
    Common Stock
    		 n/a n/a n/a n/a
    Retained Earnings
    		 10.04B 13.61B 18.32B 9.96B
    Comprehensive Income
    		 -10M -123M -370M -24M
    Shareholders Equity
    		 10.9B 13.85B 19.12B 14.14B
    Total Investments
    		 7.61B 10.44B 15.06B 10.72B

    Add to Watchlist